DNM1L and central nervous system cancer: By inhibiting the expression of macrophage migration inhibitory factor (MIF), it enhances the expression of DRP1 and p-DRP1 while simultaneously inhibiting the expression of OPA1 and MFN2 to promote mitochondrial fission, thereby promoting the progression of glioma [223].